The Indianapolis-based drugmaker also reaffirmed its 2025 revenue guidance but noted that the calculation was based on existing tariff and trade policies.

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

According to a lawsuit filed by Eli Lilly on Monday, April 7, Premier Weight Loss, a spa based in Lilly's own backyard in Indianapolis ... would have to stop manufacturing their versions of ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

INDIANAPOLIS (WISH) — A pharmaceutical titan based in Indiana is leading a global effort to protect wildlife. Eli Lilly and Company is shifting away from using horseshoe crabs, specifically ...

Pharmaceutical giant Eli Lilly (LLY) has promised to make its new weight-loss pill in the U.S. as President Donald Trump continues to push for ...

From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%. Last year was a transformative year for the Indianapolis-based pharmaceutical giant ...